The landscape of DNA methylation amid a perfect storm of autism aetiologies

Nature Reviews Neuroscience

Volumn 17, Issue 7, 2016, Pages 411-423

  Ciernia, Annie Vogel ^a   LaSalle, Janine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLURACIL; 5 METHYLCYTOSINE; ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CARRIER PROTEIN; CYTOSINE; DNA; DNA BASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GENOMIC DNA; GUANINE; METHYL CPG BINDING PROTEIN 2; PESTICIDE; PYRIMIDINE; S ADENOSYLMETHIONINE; TEN ELEVEN TRANSLOCASE 1; TEN ELEVEN TRANSLOCASE 2; TEN ELEVEN TRANSLOCASE 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN; CHROMATIN;

ADULTHOOD; AUTISM; BRAIN DEVELOPMENT; COPY NUMBER VARIATION; CPG ISLAND; DEMETHYLATION; DIET SUPPLEMENTATION; DNA METHYLATION; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HAPPY PUPPET SYNDROME; HUMAN; INFECTION; LIFESPAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; ANIMAL; CHROMATIN; GENETIC EPIGENESIS; GENETICS; METABOLISM;

ANIMALS; AUTISM SPECTRUM DISORDER; AUTISTIC DISORDER; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; RETT SYNDROME;

EID: 84965071432     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn.2016.41     Document Type: Review

References (132)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Arlington, 2013).
2. Doshi-Velez F, Ge Y, & Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 133, e54-e63 (2013).
3. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators &Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years -Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill. Summ. 63, 1-21 (2014).
4. Hallmayer J, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68, 1095-1102 (2011).
5. Kalkbrenner A. E, Schmidt R. J, & Penlesky A. C. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr. Probl. Pediatr. Adolesc. Health Care 44, 277-318 (2014).
6. Krumm N, ORoak B. J, Shendure J, & Eichler E. E. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 37, 95-105 (2014).
7. Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16, 551-563 (2015).
8. Gaugler T, et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46, 881-885 (2014).
9. Sandin S, et al. The familial risk of autism. JAMA 311, 1770-1777 (2014).
10. Schmidt R. J, et al. Maternal periconceptional folic acid intake and risk for developmental delay and autism spectrum disorder: a case-control study. Am. J. Epidemiol. 175, S126 (2012).
11. Schmidt R. J. Maternal folic acid supplements associated with reduced autism risk in the child. Evid. Based. Med. 18, e53 (2013).
12. Suren P, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. J. Am. Med. Assoc. 309, 570-577 (2013).
13. Lee B. K, et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav. Immun. 44, 100-105 (2015).
14. Fang S. Y, Wang S, Huang N, Yeh H. H, & Chen C. Y. Prenatal infection and autism spectrum disorders in childhood: a population-based case-control study in Taiwan. Paediatr. Perinat. Epidemiol. 29, 307-316 (2015).
15. Keil A. P, Daniels J. L, & Hertz-Picciotto I. Autism spectrum disorder, flea and tick medication, and adjustments for exposure misclassification: the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Environ. Health 13, 3 (2014).
16. Shelton J. F, et al. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ. Health Perspect. 122, 1103-1109 (2014).
17. Lasalle J. Epigenetic layers and players underlying neurodevelopment. Trends Neurosci. 36, 460-470 (2013).
18. Lister R, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
19. Lister R, et al. Global epigenomic reconfiguration during mammalian brain development. Science. 341, 629-643 (2013).
20. Ziller M. J, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477-481 (2013).
21. Schultz M. D, et al. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature 523, 212-216 (2015).
22. Hon G. C, et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet. 45, 1198-1206 (2013).
23. Mo A, et al. Epigenomic signatures of neuronal diversity in the mammalian brain. Neuron 86, 1369-1384 (2015).
24. Goto K, et al. Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice. Differentiation 56, 39-44 (1994).
25. Li E, Bestor T. H, & Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
26. Watanabe D, Suetake I, Tada T, & Tajima S. Stage-And cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis. Mech. Dev. 118, 187-190 (2002).
27. Feng J, Chang H, Li E, & Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J. Neurosci. Res. 79, 734-746 (2005).
28. Okano M, Bell D. W, Haber D. A, & Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
29. Tahiliani M, et al. Conversion of 5 methylcytosine to 5 hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
30. He Y. F, et al. Tet-mediated formation of 5 carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011).
31. Ito S, et al. Tet proteins can convert 5 methylcytosine to 5 formylcytosine and 5 carboxylcytosine. Science 333, 1300-1303 (2011).
32. Guo J. U, Su Y, Zhong C, Ming G. L, & Song H. Hydroxylation of 5 methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434 (2011).
33. Szwagierczak A, Bultmann S, Schmidt C. S, Spada F, & Leonhardt H. Sensitive enzymatic quantification of 5 hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 38, e181 (2010).
34. Gu T. P, et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606-610 (2011).
35. Dawlaty M. M, et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9, 166-175 (2011).
36. Li Z, et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509-4518 (2011).
37. Dawlaty M. M, et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev. Cell 24, 310-323 (2013).
38. Szulwach K. E, et al. 5 hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14, 1607-1616 (2011).
39. Wen L, et al. Whole-genome analysis of 5 hydroxymethylcytosine and 5 methylcytosine at base resolution in the human brain. Genome Biol. 15, R49 (2014).
40. Song C. X, et al. Genome-wide profiling of 5 formylcytosine reveals its roles in epigenetic priming. Cell 153, 678-691 (2013).
41. Schanen N. C. Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 15 (Suppl. 2), R138-R150 (2006).
42. Lasalle J. M. Epigenomic strategies at the interface of genetic and environmental risk factors for autism. 58 396-401 (2013).
43. Tatton-Brown K, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 46, 385-388 (2014).
44. Sanders S. J, et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215-1233 (2015).
45. Leung K. N, Chamberlain S. J, Lalande M, & Lasalle J. M. Neuronal chromatin dynamics of imprinting in development and disease. J. Cell. Biochem. 112, 365-373 (2011).
46. LaSalle J. M, Reiter L. T, & Chamberlain S. J. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders. Epigenomics 7, 1213-1228 (2015).
47. LaSalle J. M, & Yasui D. H. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 1, 119-130 (2009).
48. Cukier H. N, et al. Novel variants identified in methyl-CpG-binding domain genes in autistic individuals. Neurogenetics 11, 291-303 (2010).
49. Spruijt C. G, et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013).
50. Lyst M. J, & Bird A. Rett syndrome: a complex disorder with simple roots. Nat. Rev. Genet. 16, 261-275 (2015).
51. Woods R, et al. Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum. Mol. Genet. 21, 2399-2411 (2012).
52. Jones P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492 (2012).
53. Numata S, et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am. J. Hum. Genet. 90, 260-272 (2012).
54. Maunakea A. K, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253-257 (2010).
55. Kim M, et al. Dynamic changes in DNA methylation and hydroxymethylation when hES cells undergo differentiation toward a neuronal lineage. Hum. Mol. Genet. 23, 657-667 (2014).
56. Smith E. Y, Futtner C. R, Chamberlain S. J, Johnstone K. a, & Resnick J. L. Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus. PLoS Genet. 7, e1002422 (2011).
57. Christensen B. C, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CPG island context. PLoS Genet. 5, e1000602 (2009).
58. Schroeder D. I, Lott P, Korf I, & LaSalle J. M. Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res. 21, 1583-1591 (2011).
59. Schroeder D, et al. The human placenta methylome. Proc. Natl Acad. Sci. USA 110, 6037-6042 (2013).
60. Hansen K. D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-775 (2011).
61. Schroeder D. I, et al. Early developmental and evolutionary origins of gene body DNA methylation patterns in mammalian placentas. PLOS Genet. 11, e1005442 (2015).
62. Novakovic B, & Saffery R. The ever growing complexity of placental epigenetics -role in adverse pregnancy outcomes and fetal programming. Placenta 33, 959-970 (2012).
63. Stadler M. B, et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 484, 550-550 (2012).
64. Guo H, et al. The DNA methylation landscape of human early embryos. Nature 511, 606-610 (2014).
65. Smith Z. D, et al. DNA methylation dynamics of the human preimplantation embryo. Nature 511, 611-615 (2014).
66. Gkountela S, et al. DNA demethylation dynamics in the human prenatal germline. Cell 161, 1425-1436 (2015).
67. Tang W. W. C, et al. A unique gene regulatory network resets the human germline epigenome for development. Cell 161 1453-1467 (2015).
68. Guo F, et al. The transcriptome and DNA methylome landscapes of human primordial germ cells. Cell 161, 1437-1452 (2015).
69. Hernandez D. G, et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum. Mol. Genet. 20, 1164-1172 (2011).
70. Jaffe A. E, et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat. Neurosci. 19, 4-7 (2015).
71. Wang T, et al. Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum. Mol. Genet. 21, 5500-5510 (2012).
72. Tognini P, et al. Experience-dependent DNA methylation regulates plasticity in the developing visual cortex. Nat. Neurosci. 18, 956-958 (2015).
73. Nord A. S, Pattabiraman K, Visel A, & Rubenstein J. L. R. Review genomic perspectives of transcriptional regulation in forebrain development. Neuron 85, 27-47 (2015).
74. Gregory S. G, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 7, 62 (2009).
75. Zhu L, et al. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum. Mol. Genet. 23, 1563-1578 (2014).
76. Zhubi, a et al. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5 hmC in autism spectrum disorder (ASD) cerebellum. Transl Psychiatry 4, e349 (2014).
77. Jiang Y. H, et al. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet. 131, 1-10 (2004).
78. Nagarajan R. P, Hogard A. R, Gwye Y, Martin M. R, & Lasalle J. M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1, 1-11 (2006).
79. Nardone S, et al. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl Psychiatry 4, e433 (2014).
80. Ladd-Acosta C, et al. Common DNA methylation alterations in multiple brain regions in autism. Mol. Psychiatry 19, 862-871 (2014).
81. Schwenk J, et al. High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes. Neuron 74, 621-633 (2012).
82. Nicholson R. H, et al. Phemx, a novel mouse gene expressed in hematopoietic cells maps to the imprinted cluster on distal chromosome 7. Genomics 68, 13-21 (2000).
83. Zhu X, et al. C11orf21 a novel gene within the Beckwith-Wiedemann syndrome region in human chromosome 11p15.5. Gene 256 311-317 (2000).
84. Gartlan K. H, et al. A complementary role for the tetraspanins CD37 and Tssc6 in cellular immunity. J. Immunol. 185, 3158-3166 (2010).
85. Hemler M. E. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422 (2003).
86. Voineagu I, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380-384 (2011).
87. Estes M. L, & Mcallister A. K. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat. Rev. Neurosci. 16, 469-486 (2015).
88. Takano T. Role of microglia in autism: recent advances. Dev. Neurosci. 37, 195-202 (2015).
89. Xin Y, et al. Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS ONE 5, e11357 (2010).
90. Ziats M. N, & Rennert O. M. Aberrant expression of long noncoding RNAs in autistic brain. J. Mol. Neurosci. 49, 589-593 (2013).
91. Ginsberg M. R, Rubin R. a & Natowicz M. R. Patterning of regional gene expression in autism: new complexity. Sci. Rep. 3, 1831 (2013).
92. Rhein M, et al. DNA methylation results depend on DNA integrity -role of post mortem interval. Front. Genet. 6, 1-7 (2015).
93. Lim A. S. P, et al. 24 hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet. 10 e1004792 (2014).
94. Vaiserman A. Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?. Clin. Epigenetics 7, 96 (2015).
95. Schmidt R, et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 22, 476-485 (2011).
96. Julvez J, et al. Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort. Paediatr. Perinat. Epidemiol. 23, 199-206 (2009).
97. Tamura T, et al. Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age. Pediatrics 116, 703-708 (2005).
98. Steegers-Theunissen R. P, et al. Periconceptional maternal folic acid use of 400 g per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 4, 1-5 (2009).
99. Dominguez-Salas P, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat. Commun. 5, 1-7 (2014).
100. Barua S, et al. Single-base resolution of mouse offspring brain methylome reveals epigenome modifications caused by gestational folic acid. Epigenetics Chromatin 7, 3 (2014).
101. Hustad S, et al. The methylenetetrahydrofolate reductase 677T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am. J. Hum. Genet. 80, 846-855 (2007).
102. James S. J, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 947-956 (2006).
103. James S. J, et al. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153, 1209-1220 (2010).
104. Hannon E, et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19, 48-54 (2016).
105. Ronald A, & Hoekstra R. A. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156, 255-274 (2011).
106. Ozonoff S, et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics 128, e488-e495 (2011).
107. Robinson E. B, Lichtenstein P, Anckarsater H, Happe F, & Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc. Natl Acad. Sci. USA 110, 5258-5262 (2013).
108. Levy D, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70, 886-897 (2011).
109. Pinto D, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368-372 (2010).
110. Girirajan S, et al. Global increases in both common and rare copy number load associated with autism. Hum. Mol. Genet. 22, 2870-2880 (2013).
111. De Rubeis S, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014).
112. Iossifov I, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014).
113. Hormozdiari F, Penn O, Borenstein E, & Eichler E. E. The discovery of integrated gene networks for autism and related disorders. Genome Res. 25, 142-154 (2015).
114. Gupta S, et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat. Commun. 5, 5748 (2014).
115. Miller C. A & Sweatt J. D. Covalent modification of DNA regulates memory formation. Neuron 53, 857-869 (2007).
116. Levenson J, Roth T, & Lubin F. Evidence that DNA (cytosine 5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 281, 15763-15773 (2006).
117. Guo J. U, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat. Neurosci. 14, 1345-1351 (2011).
118. Feng J, et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423-430 (2010).
119. Kaas G. a et al. Hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79, 1086-1093 (2013).
120. Rudenko A, et al. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79, 1109-1122 (2013).
121. Li X, et al. Neocortical Tet3 mediated accumulation of 5 hydroxymethylcytosine promotes rapid behavioral adaptation. Proc. Natl Acad. Sci. USA 111, 7120-7125 (2014).
122. Day J. J, et al. DNA methylation regulates associative reward learning. Nat. Neurosci. 16, 1445-1452 (2013).
123. Bali P, Im H. I, & Kenny P. J. Methylation, memory and addiction. Epigenetics 6, 671-674 (2011).
124. Zannas A. S, & West A. E. Epigenetics and the regulation of stress vulnerability and resilience. Neuroscience 264, 157-170 (2014).
125. Yu M, et al. Tet-Assisted bisulfite sequencing of 5 hydroxymethylcytosine. Nat. Protoc. 7, 2159-2170 (2012).
126. Reinius L. E, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 7, e41361 (2012).
127. Ashwood P, et al. In search of cellular immunophenotypes in the blood of children with autism. PLoS ONE 6, e19299 (2011).
128. Smith A. K, et al. DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168, 36-44 (2015).
129. Feinberg J. I, et al. Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort. Int. J. Epidemiol. 1-12 (2015).
130. Lister R, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 470, 68-73 (2011).
131. Ohi Y, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13, 541-549 (2011).
132. Gore A, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 470, 63-67 (2011).